| P50 | author | Kristin R Laurens | Q43500944 |
| | Mizanur Khondoker | Q47163880 |
| | Patricia A Zunszain | Q47812812 |
| | Carmine Pariante | Q49754517 |
| | Alexis E Cullen | Q50741118 |
| | Hannah Dickson | Q57617994 |
| | Naghmeh Nikkheslat | Q58747371 |
| | Ben M Tappin | Q60442190 |
| | Helen L. Fisher | Q42306078 |
| P2093 | author name string | Ruth E Roberts | |
| P2860 | cites work | Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association | Q22241929 |
| | Three key regions for supervisory attentional control: evidence from neuroimaging meta-analyses | Q24020059 |
| | Adolescent maturity and the brain: the promise and pitfalls of neuroscience research in adolescent health policy | Q24628419 |
| | Toward earlier identification and preventative intervention in schizophrenia: evidence from the London Child Health and Development Study | Q26775725 |
| | Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses | Q26798039 |
| | The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials | Q26799627 |
| | Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior | Q27694728 |
| | Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study | Q28186001 |
| | A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects | Q30443918 |
| | Patterns of memory: a normative taxonomy of the Wide Range Assessment of Memory and Learning-Second Edition (WRAML-2). | Q30446850 |
| | Childhood bullying involvement predicts low-grade systemic inflammation into adulthood | Q33694393 |
| | Metabolic disease risk in children by salivary biomarker analysis | Q33733973 |
| | The association between depressive symptoms, cognitive function, and inflammation in major depression | Q44395463 |
| | Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder | Q45383496 |
| | Early postoperative systemic inflammatory response is an important determinant for adverse 2-year neurodevelopment-associated outcomes after the Norwood procedure | Q45848143 |
| | British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood | Q47294166 |
| | Variation in childhood and adolescent obesity prevalence defined by international and country-specific criteria in England and the United States | Q47335898 |
| | Elevated C-reactive protein levels may be a predictor of persistent unfavourable symptoms in patients with mild traumatic brain injury: a preliminary study | Q48129999 |
| | Involvement of the inferior frontal junction in cognitive control: meta-analyses of switching and Stroop studies | Q48919079 |
| | Treatment response and cognitive impairment in major depression: association with C-reactive protein | Q48950624 |
| | Psychotic-like experiences in a community sample of 8000 children aged 9 to 11 years: an item response theory analysis. | Q50509988 |
| | C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. | Q50578956 |
| | Systemic markers of inflammation and cognitive decline in old age. | Q50804243 |
| | Validation of a high-sensitivity assay for C-reactive protein in human saliva. | Q51891330 |
| | Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years. | Q51908217 |
| | Serum inflammatory proteins and cognitive decline in older persons. | Q51930816 |
| | Inflammation markers in relation to cognition in a healthy aging population. | Q52008621 |
| | Centers for Disease Control and Prevention 2000 Growth Charts for the United States: Improvements to the 1977 National Center for Health Statistics Version | Q57196021 |
| | Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia | Q59784211 |
| | A self-administered rating scale for pubertal development | Q72812264 |
| | C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia | Q80301115 |
| | White blood cell count and psychomotor cognitive performance in the elderly | Q83784631 |
| | Cortisol awakening response and diurnal cortisol among children at elevated risk for schizophrenia: relationship to psychosocial stress and cognition | Q33785320 |
| | Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study | Q33831010 |
| | Cognitive impairment in chronic obstructive pulmonary disease | Q33916282 |
| | Detection of homocysteine and C-reactive protein in the saliva of healthy adults: comparison with blood levels | Q34052672 |
| | Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study | Q34063614 |
| | Inflammation and rate of cognitive change in high-functioning older adults | Q34187062 |
| | Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia. | Q34213907 |
| | Psychometric properties of the strengths and difficulties questionnaire | Q34431728 |
| | Detection and potential utility of C-reactive protein in saliva of neonates | Q34551755 |
| | Early origins of inflammation: An examination of prenatal and childhood social adversity in a prospective cohort study | Q34716708 |
| | Associations between inflammation and cognitive function in African Americans and European Americans | Q34729552 |
| | Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis | Q34891920 |
| | Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis | Q34935593 |
| | Association of C-reactive protein with cognitive impairment | Q35591752 |
| | A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book | Q35762122 |
| | Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife | Q35787860 |
| | Assessing salivary C-reactive protein: longitudinal associations with systemic inflammation and cardiovascular disease risk in women exposed to intimate partner violence | Q35906872 |
| | The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis | Q35955612 |
| | Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation. | Q35968008 |
| | Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. | Q36045153 |
| | C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis | Q36190768 |
| | Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars | Q36215688 |
| | Statin therapy in Alzheimer's disease | Q36546516 |
| | Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants | Q36637831 |
| | Elevated salivary C-reactive protein predicted by low cardio-respiratory fitness and being overweight in African children | Q37041673 |
| | Inflammatory cytokines in pediatric obstructive sleep apnea | Q37354747 |
| | Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia | Q37389579 |
| | Nutrition, inflammation, and cognitive function. | Q37399379 |
| | Prenatal maternal depression is associated with offspring inflammation at 25 years: a prospective longitudinal cohort study. | Q37648202 |
| | Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset | Q38392954 |
| | Acute phase protein and cytokine levels in serum and saliva: a comparison of detectable levels and correlations in a depressed and healthy adolescent sample | Q39356735 |
| | Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder | Q39867864 |
| | The reliability and validity of the self-ordered pointing task | Q40239562 |
| | Neonatal Biomarkers of Inflammation: Correlates of Early Neurodevelopment and Gait in Very-Low-Birth-Weight Preterm Children | Q41089459 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 221-229 | |
| P577 | publication date | 2017-07-07 | |
| P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
| P1476 | title | The relationship between salivary C-reactive protein and cognitive function in children aged 11-14years: Does psychopathology have a moderating effect? | |
| P478 | volume | 66 | |